Amphastar Pharmaceuticals (AMPH) Change in Cash (2013 - 2026)

Amphastar Pharmaceuticals' Change in Cash history runs 14 years deep, the most recent figure standing at $762000.0 for Q1 2026.

• On a quarterly basis, Change in Cash fell 97.56% year-over-year to $762000.0 in Q1 2026; TTM through Mar 2026 was -$11.8 million, a 35.52% increase from a year earlier, with the FY2025 full-year figure at $18.6 million, up 153.9% from the prior year.
• Change in Cash rose to $762000.0 in Q1 2026 per AMPH's latest filing, from -$46.1 million in the prior quarter.
• Across five years, Change in Cash topped out at $119.8 million in Q3 2023 and bottomed at -$126.5 million in Q4 2023.
• The 5-year median for Change in Cash is $762000.0 (2026), against an average of $2.6 million.
• Biggest YoY gain for Change in Cash was 1443.62% in 2023; the steepest drop was 10938.92% in 2023.
• Year by year, Change in Cash stood at -$1.1 million in 2022, then tumbled by 10938.92% to -$126.5 million in 2023, then soared by 67.98% to -$40.5 million in 2024, then fell by 13.78% to -$46.1 million in 2025, then surged by 101.65% to $762000.0 in 2026.
• Per Business Quant, the three latest AMPH Change in Cash figures stand at $762000.0 (Q1 2026), -$46.1 million (Q4 2025), and $28.6 million (Q3 2025).